ArticlePloS one2014

Chronic treatment with novel small molecule Hsp90 inhibitors rescues striatal dopamine levels but not α-synuclein-induced neuronal cell loss.

Nikolaus R McFarland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.